跳至主要内容
临床试验/JPRN-UMIN000011223
JPRN-UMIN000011223招募中未知

Evaluation of efficacy and safety of Dabigaran in patients with catheter ablation for atrial fibrillation. - Evaluation of efficacy and safety of Dabigaran during catheter ablation

Osaka City University Graduate School of Medicine0 个研究点目标入组 140 人开始时间: 2013年7月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with chronic atrial fibrillation, valvular heart diseases, severe renal dysfunction, history of allergy of this drug, bleeding tendency, high risk of bleeding, subdural catheter, and antithrombotic drugs.

研究者

发起方
Osaka City University Graduate School of Medicine

相似试验